Risk of severe dengue during secondary infection: A population-based cohort study in Taiwan.

Autor: Shih HI; Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Wang YC; Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Wang YP; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan; National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Miaoli County, Taiwan., Chi CY; National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Miaoli County, Taiwan; Department of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: pedchi@nhri.org.tw., Chien YW; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Occupational and Environmental Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address: yuwenchien@mail.ncku.edu.tw.

Publikováno v: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2024 Oct; Vol. 57 (5), pp. 730-738. Date of Electronic Publication: 2024 Jul 11.

Inhibitory peptides derived from Hepatitis C virus NS5A for reducing clinical symptoms of dengue virus infection.

Autor: Lee Y; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Seo M; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Yun SH; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Yu M; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Kim HJ; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Cho HW; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Byeon HW; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Park SO; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Uyangaa E; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea., Jeon H; BIO R&D Center, DaehanNupharm Co. Ltd., 20, Changeop-ro 57beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13449, Republic of Korea., Lee M; BIO R&D Center, DaehanNupharm Co. Ltd., 20, Changeop-ro 57beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13449, Republic of Korea., Kwon YD; BIO R&D Center, DaehanNupharm Co. Ltd., 20, Changeop-ro 57beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13449, Republic of Korea., Eo SK; College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea. Electronic address: vetvirus@jbnu.ac.kr.

Publikováno v: Antiviral research [Antiviral Res] 2024 Nov; Vol. 231, pp. 106018. Date of Electronic Publication: 2024 Oct 09.

Dengue Envelope Protein as a Cytotoxic Factor Inducing Hemorrhage and Endothelial Cell Death in Mice.

Autor: Lien TS; Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan., Sun DS; Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan., Wu WS; Division of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.; Department of Laboratory Medicine and Biotechnology, College of Medicine, Tzu Chi University, Hualien 970, Taiwan., Chang HH; Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 09; Vol. 25 (19). Date of Electronic Publication: 2024 Oct 09.

Are viral loads in the febrile phase a predictive factor of dengue disease severity?

Autor: Dayarathna S; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Kuruppu H; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Silva T; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.; Faculty of Medicine, General Sir John Kotelawala Defence University, Rathmalana, Sri Lanka., Gomes L; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Shyamali NLA; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Jeewandara C; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Ariyaratne D; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Ramu ST; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka., Wijewickrama A; National Institute of Infectious Diseases, Angoda, Sri Lanka., Ogg GS; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Malavige GN; Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka. gathsaurie.malavige@ndm.ox.ac.uk.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. gathsaurie.malavige@ndm.ox.ac.uk.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2024 Nov 05; Vol. 24 (1), pp. 1248. Date of Electronic Publication: 2024 Nov 05.

Proceedings of the dengue endgame summit: Imagining a world with dengue control.

Autor: Wegman AD; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA., Kalimuddin S; Department of Infectious Diseases, Singapore General Hospital, Singapore; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Marques ETA; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA., Adams LE; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico, USA., Rothman AL; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, USA., Gromowski GD; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Wang TT; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA; Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA., Weiskopf D; Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA., Hibberd ML; London School of Hygiene & Tropical Medicine Department of Infection Biology, Keppel Street, London WC1E 7HT, England; Associate Faculty, National Institutes of Health, University of the Philippines, Philippines., Alex Perkins T; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA., Christofferson RC; Department of Pathobiological Sciences, Louisiana School of Veterinary Medicine, Baton Rouge, LA, USA., Gunale B; Serum Institute of India Pvt. Ltd., Pune, India., Kulkarni PS; Serum Institute of India Pvt. Ltd., Pune, India., Rosas A; Takeda Pharmaceuticals, Inc, Boston, MA, USA., Macareo L; Merck & Co., Inc., Rahway, NJ 07065, USA., Yacoub S; Oxford University Clinical Research Unit (OUCRU) Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine and Global Health, University of Oxford, UK., Eong Ooi E; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore., Paz-Bailey G; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico, USA., Thomas SJ; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, NY 13210, USA. Electronic address: ThomStep@upstate.edu., Waickman AT; Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA; Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, NY 13210, USA. Electronic address: waickmaa@upstate.edu.

Publikováno v: Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126071. Date of Electronic Publication: 2024 Jun 17.